liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Treatment Related to Urinary Tract Infections Is Associated with Delayed Diagnosis of Urinary Bladder Cancer: A Nationwide Population-based Study
Lund Univ, Sweden; Skåne Univ Hosp, Sweden.
Karolinska Inst, Sweden.
Lund Univ, Sweden.
Linköping University, Department of Biomedical and Clinical Sciences, Division of Surgery, Orthopedics and Oncology. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Center for Surgery, Orthopaedics and Cancer Treatment, Department of Urology in Östergötland.
Show others and affiliations
2025 (English)In: European Urology Oncology, E-ISSN 2588-9311, Vol. 8, no 1, p. 119-125Article in journal (Refereed) Published
Abstract [en]

Background and objective: It has been suggested that urinary tract infections (UTIs) are associated with delayed diagnosis of bladder cancer (BC). Our aim was to investigate prediagnostic treatments related to UTI and the relation to BC diagnostic delay, reflected by advanced disease at diagnosis. Methods: We used data from the BladderBaSe 2.0 with data of treatments related to UTI up to 3 yr before BC diagnosis (2008-2019) for BC patients in comparison to a matched reference population. We investigated the association between UTI treatments and more advanced disease at diagnosis in the BC cohort. We used generalized ordered logistic regression to calculate odds ratios (ORs) for more advanced disease as an ordered outcome: non-muscle-invasive BC (NMIBC), muscle-invasive BC (MIBC), and metastatic BC (MBC). Key findings and limitations: The study population included 29 921 BC patients and 149 467 matched reference subjects. The proportions of individuals receiving UTI treatment were higher in the patient groups than in the corresponding reference groups, with the greatest differences observed for the MIBC and MBC subgroups. The OR for the risk of more advanced disease (MIBC or MBC) with at least one UTI treatment versus none was 1.28 (95% confidence interval [CI] 1.19-1.37) for men and 1.42 (95 % CI 1.27- 1.58) for women. The association to risk of more advanced disease increased with the number of UTI treatments for both sexes. Conclusions and clinical implications: Further studies on the effects of treatments related to UTI in combination with other factors are needed to identify reasons for possible delays in the BC diagnostic pathway. Patient summary: We found that for patients with bladder cancer, previous antibiotic treatment for a urinary tract infection was linked to more advanced disease at diagnosis. Further studies are needed to identify reasons for possible delays in the diagnosis of bladder cancer. (c) 2024 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology. This is an open access article under the CC BY license (http://creativecommons.

Place, publisher, year, edition, pages
ELSEVIER , 2025. Vol. 8, no 1, p. 119-125
Keywords [en]
Bladder cancer; Diagnostic delay; Register-based study; Urinary tract infection
National Category
Urology
Identifiers
URN: urn:nbn:se:liu:diva-212039DOI: 10.1016/j.euo.2024.07.008ISI: 001426105100001PubMedID: 39143001Scopus ID: 2-s2.0-85218503178OAI: oai:DiVA.org:liu-212039DiVA, id: diva2:1942465
Note

Funding Agencies|Swedish Cancer Society [CAN 22 2021, CAN 2023/2807]; Swedish Research Council [2021-00859]; Lund Medical Faculty, Skne University Hospital Research Funds; Cancer Research Fund at Malm General Hospital; Maud and Birger Gustavsson Research Foundation; Hjelm Family Foundation for Medical Research; Foundation of Urological Research; Hillevi Fries Research Foun-dation; Lion's Cancer Research Foundation in Northern Sweden [LP 23-2342]

Available from: 2025-03-05 Created: 2025-03-05 Last updated: 2025-05-18

Open Access in DiVA

fulltext(550 kB)135 downloads
File information
File name FULLTEXT01.pdfFile size 550 kBChecksum SHA-512
4e31fb5626c64045cba4d0f18e6e025a4133f4cca257d52bbcdaba53115b30106404aed4e0a6ee94304346dee8198fa4118784f37aa9ccb1ecce19d21de857f4
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Jahnson, Staffan

Search in DiVA

By author/editor
Aljabery, FirasJahnson, Staffan
By organisation
Division of Surgery, Orthopedics and OncologyFaculty of Medicine and Health SciencesDepartment of Urology in Östergötland
In the same journal
European Urology Oncology
Urology

Search outside of DiVA

GoogleGoogle Scholar
Total: 136 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 136 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf